These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2049550)

  • 1. Large-scale process purification of clinical product from animal cell cultures.
    Prior CP
    Biotechnology; 1991; 17():445-78. PubMed ID: 2049550
    [No Abstract]   [Full Text] [Related]  

  • 2. Manufacture of pharmaceutical proteins from hybridomas and other cell substrates.
    Tolbert WR; Rupp RG
    Dev Biol Stand; 1989; 70():49-56. PubMed ID: 2503410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purifying antibody-plasminogen activator conjugates.
    Bode C; Runge MS; Haber E
    Bioconjug Chem; 1992; 3(4):269-72. PubMed ID: 1390979
    [No Abstract]   [Full Text] [Related]  

  • 4. A new use for existing technology - continuous precipitation for purification of recombination proteins.
    Warikoo V; Godawat R
    Biotechnol J; 2015 Aug; 10(8):1101-2. PubMed ID: 25781861
    [No Abstract]   [Full Text] [Related]  

  • 5. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process-scale purification from cell culture supernatants: monoclonal antibodies.
    Ostlund C; Borwell P; Malm B
    Dev Biol Stand; 1987; 66():367-75. PubMed ID: 3108053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive magnetic nanoparticles for monoclonal antibody purification.
    Borlido L; Moura L; Azevedo AM; Roque AC; Aires-Barros MR; Farinha JP
    Biotechnol J; 2013 Jun; 8(6):709-17. PubMed ID: 23420794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of vampire bat plasminogen activator DSPA alpha 1 in CHO and insect cells.
    Petri T; Langer G; Bringmann P; Cashion L; Shallow S; Schleuning WD; Donner P
    J Biotechnol; 1995 Feb; 39(1):75-83. PubMed ID: 7766013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
    Einarsson M; Brandt J; Kaplan L
    Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale processing & high-throughput perfusion chromatography.
    Fulton SP; Shahidi AJ; Gordon NF; Afeyan NB
    Biotechnology (N Y); 1992 Jun; 10(6):635-9. PubMed ID: 1368883
    [No Abstract]   [Full Text] [Related]  

  • 11. Alternative technologies to generate monoclonal antibodies.
    Stigbrand T; Ahlström KR; Sundström B; Makiya R; Stendahl U
    Acta Oncol; 1993; 32(7-8):841-4. PubMed ID: 8305234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of protein engineering and process optimization approaches to enhance antibody drug manufacturability.
    Conley GP; Viswanathan M; Hou Y; Rank DL; Lindberg AP; Cramer SM; Ladner RC; Nixon AE; Chen J
    Biotechnol Bioeng; 2011 Nov; 108(11):2634-44. PubMed ID: 21618474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of cell culture with continuous, on-line sterile downstream processing.
    Grandics P; Szathmary S; Szathmary Z; O'Neill T
    Ann N Y Acad Sci; 1991 Dec; 646():322-33. PubMed ID: 1809200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spin filter perfusion system for high density cell culture: production of recombinant urinary type plasminogen activator in CHO cells.
    Avgerinos GC; Drapeau D; Socolow JS; Mao JI; Hsiao K; Broeze RJ
    Biotechnology (N Y); 1990 Jan; 8(1):54-8. PubMed ID: 1367426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multi-product leached protein A assay for bioprocess samples containing recombinant human monoclonal antibodies.
    Ren D; Darlucio MR; Chou JH
    J Immunol Methods; 2011 Mar; 366(1-2):20-7. PubMed ID: 21315722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a plasminogen activator from Streptococcus uberis.
    Leigh JA
    FEMS Microbiol Lett; 1994 May; 118(1-2):153-8. PubMed ID: 8013872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale purification of monoclonal antibodies for therapeutic use.
    Garg VK
    Targeted Diagn Ther; 1990; 3():45-73. PubMed ID: 2131018
    [No Abstract]   [Full Text] [Related]  

  • 18. Real-time monitoring and control of the load phase of a protein A capture step.
    Rüdt M; Brestrich N; Rolinger L; Hubbuch J
    Biotechnol Bioeng; 2017 Feb; 114(2):368-373. PubMed ID: 27543789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of a well-characterized biotechnology product.
    Zoon K; Garnick R
    Dev Biol Stand; 1998; 96():191-7. PubMed ID: 9890531
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimization of a micro-scale, high throughput process development tool and the demonstration of comparable process performance and product quality with biopharmaceutical manufacturing processes.
    Evans ST; Stewart KD; Afdahl C; Patel R; Newell KJ
    J Chromatogr A; 2017 Jul; 1506():73-81. PubMed ID: 28551021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.